Pilot Study Efficacy and Tolerance Fish Oil Emulsion Daunorubicin and Cytarabine Treatment of AML Younger Patients
Status:
Completed
Trial end date:
2018-04-01
Target enrollment:
Participant gender:
Summary
Pilot study of the efficacy and tolerance of the adjunction of a Fish oil emulsion to
daunorubicin and cytarabine chemotherapy for the treatment of Acute MYeloblastic Leukemia of
Younger patients (under 61 years) with high-risk cytogenetics.